High levels of a combination of both DARPP-32 and t-DARPP expression have been linked with poor survival of breast cancer patients (n = 230)21 and t-DARPP expression has been shown to increase during mammary tumour development22,23. The gene discussed is PPP1R1B; the disease is breast carcinoma.